QLS-111

N/A

Report date: 2026/02/25 20:02:36
NME

Base Information

Drug NameQLS-111
Drug Alias NameQLS-111
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionKATP channels modulators
TargetsKATP channels
Therapy Area/IndicationsDiabetic RetinopathyLow Tension GlaucomaGlaucoma, Open-Angle +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSouth Korea
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesQlaris Bio IncMayo Clinic
China Registration ClassN/A

Develop Information

Active CompaniesQlaris Bio Inc
Inactive CompaniesN/A
Active IndicationsDiabetic RetinopathyLow Tension GlaucomaGlaucoma, Open-Angle +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A